1.100
+0,00%
2026-10-16
Fundamental Analysis
41 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +3.7% | -47.3% | 2 / 3 | +8.9% | -0.01 pp | +10.41 pp | -153.7% | -21.47 | — | 18,2 | +8,9% | −14,5 | +3,7% | — | -1.78 | — |
| Pts | 0 | 0 | 8 | 0 | 4 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.100 (close price on 2026-10-16)EPS (TTM): −1.504,3
Financial charts
1.Revenue & growth
VND bn18,2Q2/26
1.Revenue & growth
VND bn18,2Q2/26
2.Profit & growth
VND bn-14,5Q2/26
3.Profit mix (Penman)
VND bn-101Q2/26
4.Margins & cost structure
%70.6%Q2/26
5.Returns & cash cycle
% · days2.9%Q2/26
6.Earnings quality & cash
VND bn-84,1Q2/26
7.Asset structure
VND bn1.804Q2/26
8.Funding & debt health
VND bn · times1.804Q2/26
9.Revenue backlog
VND bn260Q2/26
10.Valuation
times · %-0,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-244Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26